Searched for
NOVARTIS NEWS
‘The count is up to 13’: Congressman presses FBI over Matthew Sullivan’s suspicious death in missing scientists mysteryRep. Eric Burlison is demanding answers from the FBI regarding the suspicious deaths and disappearances of at least 13 American scientists ...- Mystery deepens as FBI investigates missing US scientists; House Oversight Committee launches parallel probeA series of unexplained deaths and disappearances involving US scientists and government personnel, including a retired Air Force general, ...
- Novartis exits India arm, ChrysCapital-led group buys 70.68% stake for ₹1,446 croreSwiss drugmaker Novartis AG is selling its 70.68% stake in its Indian unit for Rs 1,446 crore to a consortium led by ChrysCapital. This div...
- Novartis India shares soar 20% as Swiss parent plans full exit in Rs 1,446 crore dealNovartis India shares surged nearly 18% after its Swiss parent announced the sale of its 70.68% stake for approximately Rs 1,446 crore. A c...
- US President Donald Trump to announce new deals to lower drug prices, White House saysPresident Trump is set to announce new agreements Friday aimed at lowering prescription drug prices, with major drugmakers like AbbVie, Bri...
- Novartis to acquire Avidity Biosciences for about $12 billionNovartis is acquiring U.S. biotech firm Avidity Biosciences for approximately $12 billion in cash to expand its rare disease treatment port...
- Novartis signs up to $5.2 billion heart drugs licensing deal with China's ArgoNovartis has entered into a licensing and options agreement with Argo Biopharmaceutical, valued at up to $5.2 billion. The deal encompasses...
- Divi's Lab stock slips on US supply worries"While the exact revenue from Entresto-related supplies is undisclosed, it contributes a meaningful share to the overall business. However,...
- Novartis to slash up to 8,000 jobs globallyNovartis said in an emailed statement it had made good progress in implementing its new organisational structure that involved integrating ...
- Bayer's consumer health unit plans to step up India playIn an interview to ET, Sandeep Verma, country head, India, Bayer consumer health division in India, said the company will use its global ex...
- Novartis turning to technology to manage business: Bertrand Bodson, Chief Digital OfficerSwiss drugmaker Novartis is turning to tech to deal with the pharma business in times of pandemic, as companies go virtual. Bertrand Bodson...
- Mega diabetes drug to be cheaper soonWith Novartis losing patent protection for Vildagliptin in December, the cost of therapy is expected to reduce by over 50%.
- Novartis India denies delisting plans; stock plunges over 13%The stock had ended 15.72 per cent in previous trade following media reports that “Novartis AG was planning to delist Indian units.
- Novartis buys GSK's cancer drugs for $14.5 billion in a 3-way dealThe collaboration between the two will create a new world-leading consumer healthcare business with $10 billion in annual sales.
- Novartis sacks 18 for fabricating sales dataThe Indian subsidiary of Swiss drug maker Novartis has dismissed some 18 middle-level sales executives for fabricating and inflating the sa...
- Why was Novartis denied a patent for Glivec in India?If Novartis had won the case, it would have been granted a monopoly on Glivec, and denied Indian companies the right to make the drug.
- Mylan sues USFDA for allowing Ranbaxy to sell Diovan's generic versionMylan has sued USFDA for not allowing it to market a generic version of medicine Diovan, saying that Ranbaxy has lost its exclusivity for t...
- Pharma cos shares extend gain on BSEShares of multinational pharmaceutical companies on Wednesday extended gains on the BSE, cheering their parents’ move to hike stake in thes...
- Novartis HQ silent, MSF expresses reliefNovartis headquarters in Basel is still digesting the rejection of pharma giant’s appeal in the Madras High Court. A press release from Nov...
- World opinion was against NovartisThe news that the Madras High Court has rejected the appeal by the Swiss pharma giant Novartis challenging the constitutionality of section...
Load More
